BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 31199602)

  • 41. Clinical and Genomic Characteristics of Small Cell Lung Cancer in Never Smokers: Results From a Retrospective Multicenter Cohort Study.
    Thomas A; Mian I; Tlemsani C; Pongor L; Takahashi N; Maignan K; Snider J; Li G; Frampton G; Ali S; Kim S; Nichols S; Rajapakse V; Guha U; Sharon E; Fujimoto J; Moran CA; Wistuba II; Wei JS; Khan J; Szabo E; Torres AZ; Carson KR
    Chest; 2020 Oct; 158(4):1723-1733. PubMed ID: 32464188
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Evaluation of role of Notch3 signaling pathway in human lung cancer cells.
    Hassan WA; Yoshida R; Kudoh S; Motooka Y; Ito T
    J Cancer Res Clin Oncol; 2016 May; 142(5):981-93. PubMed ID: 26838758
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Expression and clinical significance of genes frequently mutated in small cell lung cancers defined by whole exome/RNA sequencing.
    Iwakawa R; Kohno T; Totoki Y; Shibata T; Tsuchihara K; Mimaki S; Tsuta K; Narita Y; Nishikawa R; Noguchi M; Harris CC; Robles AI; Yamaguchi R; Imoto S; Miyano S; Totsuka H; Yoshida T; Yokota J
    Carcinogenesis; 2015 Jun; 36(6):616-21. PubMed ID: 25863124
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Exploring the molecular features and genetic prognostic factors of pulmonary high-grade neuroendocrine carcinomas.
    Wang H; Yan L; Zhu Y; Sun W; Yang X; Liu X; Chi K; Huang X; Zhou L; Lin D
    Hum Pathol; 2023 Dec; 142():81-89. PubMed ID: 37742943
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Identification of candidate biomarkers and pathways associated with SCLC by bioinformatics analysis.
    Wen P; Chidanguro T; Shi Z; Gu H; Wang N; Wang T; Li Y; Gao J
    Mol Med Rep; 2018 Aug; 18(2):1538-1550. PubMed ID: 29845250
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Use of targeted next generation sequencing to characterize tumor mutational burden and efficacy of immune checkpoint inhibition in small cell lung cancer.
    Ricciuti B; Kravets S; Dahlberg SE; Umeton R; Albayrak A; Subegdjo SJ; Johnson BE; Nishino M; Sholl LM; Awad MM
    J Immunother Cancer; 2019 Mar; 7(1):87. PubMed ID: 30922388
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Mutation profile of non-small cell lung cancer revealed by next generation sequencing.
    Chang YS; Tu SJ; Chen YC; Liu TY; Lee YT; Yen JC; Fang HY; Chang JG
    Respir Res; 2021 Jan; 22(1):3. PubMed ID: 33407425
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Identification of deregulation of apoptosis and cell cycle in neuroendocrine tumors of the lung via NanoString nCounter expression analysis.
    Walter RF; Werner R; Ting S; Vollbrecht C; Theegarten D; Christoph DC; Schmid KW; Wohlschlaeger J; Mairinger FD
    Oncotarget; 2015 Sep; 6(28):24690-8. PubMed ID: 26008974
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Validating a targeted next-generation sequencing assay and profiling somatic variants in Chinese non-small cell lung cancer patients.
    Jiang R; Zhang B; Teng X; Hu P; Xu S; Zheng Z; Liu R; Tang T; Ye F
    Sci Rep; 2020 Feb; 10(1):2070. PubMed ID: 32034196
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Clinical genomic profiling to identify actionable alterations for very early relapsed triple-negative breast cancer patients in the Chinese population.
    Wang L; Zhai Q; Lu Q; Lee K; Zheng Q; Hong R; Wang S
    Ann Med; 2021 Dec; 53(1):1358-1369. PubMed ID: 34396843
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Molecular profiling and prognostic biomarkers in chinese non-small cell lung cancer cohort.
    Shen F; Guo W; Song X; Wang B
    Diagn Pathol; 2023 Jun; 18(1):71. PubMed ID: 37301854
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Repeatedly next-generation sequencing during treatment follow-up of patients with small cell lung cancer.
    JiaXin Y; XiaoFeng C; PengFei C; Songchen Z; Ziling L
    Medicine (Baltimore); 2023 Jun; 102(26):e34143. PubMed ID: 37390276
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Mutation Spectrum of
    Mao L; Zhao W; Li X; Zhang S; Zhou C; Zhou D; Ou X; Xu Y; Tang Y; Ou X; Hu C; Ding X; Luo P; Yu S
    Pathol Oncol Res; 2021; 27():602726. PubMed ID: 34257561
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Genomic Profiling of Circulating Tumor DNA from Patients with Extensive-Stage Small Cell Lung Cancer Identifies Potentially Actionable Alterations.
    Yang J; Wang X; Lu J; Chen H; Zhao X; Gao C; Bai Y; Zhang Q; Fu X; Zhang X
    J Cancer; 2021; 12(17):5099-5105. PubMed ID: 34335926
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Comprehensive Genomic Analysis for Small Cell Lung Cancer].
    Shibata Y; Udagawa H; Matsumoto S; Goto K
    Gan To Kagaku Ryoho; 2021 Apr; 48(4):476-485. PubMed ID: 33976029
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Targeted deep sequencing from multiple sources demonstrates increased NOTCH1 alterations in lung cancer patient plasma.
    Liao Y; Ma Z; Zhang Y; Li D; Lv D; Chen Z; Li P; Ai-Dherasi A; Zheng F; Tian J; Zou K; Wang Y; Wang D; Cordova M; Zhou H; Li X; Liu D; Yu R; Zhang Q; Zhang X; Zhang J; Zhang X; Zhang X; Li Y; Shao Y; Song L; Liu R; Wang Y; Sufiyan S; Liu Q; Owen GI; Li Z; Chen J
    Cancer Med; 2019 Sep; 8(12):5673-5686. PubMed ID: 31369215
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Prognostic biomarkers correlated with immune infiltration in non-small cell lung cancer.
    Xu F; Cui WQ; Liu C; Feng F; Liu R; Zhang J; Sun CG
    FEBS Open Bio; 2023 Jan; 13(1):72-88. PubMed ID: 36282125
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Multi-region exome sequencing reveals the intratumoral heterogeneity of surgically resected small cell lung cancer.
    Zhou H; Hu Y; Luo R; Zhao Y; Pan H; Ji L; Zhou T; Zhang L; Long H; Fu J; Wen Z; Wang S; Wang X; Lin P; Yang H; Wang J; Song M; Yi X; Yang L; Xia X; Guan Y; Fang W; Yang Y; Hong S; Huang Y; Li P; Zhang Y; Zhou N
    Nat Commun; 2021 Sep; 12(1):5431. PubMed ID: 34521849
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Multiplex genomic test of mutation and fusion genes in small biopsy specimen of lung cancer.
    Oshita F; Kasajima R; Miyagi Y
    J Exp Ther Oncol; 2016 Jul; 11(3):189-194. PubMed ID: 28471124
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Metabolic radiogenomics in lung cancer: associations between FDG PET image features and oncogenic signaling pathway alterations.
    Kim G; Kim J; Cha H; Park WY; Ahn JS; Ahn MJ; Park K; Park YJ; Choi JY; Lee KH; Lee SH; Moon SH
    Sci Rep; 2020 Aug; 10(1):13231. PubMed ID: 32764738
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.